ArQule Provides Proprietary Pipeline Update for AKT Inhibitors
January 28, 2016 07:30 ET
|
ArQule, Inc.
First cohort dosed in phase 1 trial with ARQ 092 in Proteus syndromeArQule receives Investigational New Drug approval for ARQ 751BURLINGTON, Mass., Jan. 28, 2016 (GLOBE NEWSWIRE) -- ArQule, Inc....
Miracle Flights Welcomes New CEO
January 19, 2016 14:34 ET
|
Miracle Flights
LAS VEGAS, Jan. 19, 2016 (GLOBE NEWSWIRE) -- The nation's leading health and welfare flight organization, Miracle Flights, recently named Mark E. Brown the new CEO of the organization. The charity...
Miracle Flights' Founder and National President Retires After 30 Years
January 13, 2016 10:53 ET
|
Miracle Flights
LAS VEGAS, Jan. 13, 2016 (GLOBE NEWSWIRE) -- After an impressive career spanning over 3 decades of charitable service, Miracle Flights Founder and National President, Ann McGee, announces her...
Miracle Flights Looks to Connect With Past Patients
January 12, 2016 11:45 ET
|
Miracle Flights
LAS VEGAS, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Miracle Flights, previously known as "Miracle Flights for Kids" or "Angel Planes," is seeking to reconnect with patients and families that flew with the...
Miracle Flights Performs 623 Life-Saving Flights for December 2015
January 07, 2016 15:23 ET
|
Miracle Flights
LAS VEGAS, Jan. 7, 2016 (GLOBE NEWSWIRE) -- Miracle Flights, the nation's leading health and welfare flight organization, reported 623 life-saving flights for the month of December 2015. This comes as...
Achillion Announces Upcoming Oral Presentation at the 57th Annual Meeting of the American Society of Hematology and Nomination of ACH-4471, a Novel Small Molecule Factor D Inhibitor, for Clinical Development
December 05, 2015 17:00 ET
|
Achillion Pharmaceuticals, Inc.
- Presentation will highlight ACH-4471, a highly potent, specific, and orally-administered factor D inhibitor, and preclinical data on its ability to block hemolysis of paroxysmal nocturnal...
ArQule to Present at Leerink Partners 4th Annual Rare Disease Roundtable on September 30, 2015
September 25, 2015 07:30 ET
|
ArQule, Inc.
BURLINGTON, Mass., Sept. 25, 2015 (GLOBE NEWSWIRE) -- ArQule, Inc. (NASDAQ:ARQL) today announced that Dr. Brian Schwartz, Head of Research and Development and Chief Medical Officer, will present...
AAHOA Members Provide Rooms to Man Running Across the Country for a Cause
April 20, 2015 10:03 ET
|
Asian American Hotel Owners Association
ATLANTA, April 20, 2015 (GLOBE NEWSWIRE) -- Noah Coughlan is running 3,100 miles from New York to California, and the Asian American Hotel Owners Association (AAHOA) is helping him during his...
Dohmen Life Science Services Acquires Chicago Company Focused on Rare Disease Marketing
January 06, 2015 13:30 ET
|
Dohmen
MILWAUKEE, Jan. 6, 2015 (GLOBE NEWSWIRE) -- Dohmen Life Science Services, a provider of outsourced business services for biopharma and medtech innovators, announced today it has acquired Siren...
Media Alert: Innovative Business Opportunities in Neurofibromatosis
June 09, 2014 10:19 ET
|
Children's Tumor Foundation
NEW YORK, N.Y., June 9, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...